ArticleCureus2021

Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial.

Flavio A Cadegiani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.